Catherine Cole, Ph.D., is the Director of Strategic Pricing and Access at Gilead Sciences, where they have also held positions as Associate Director and Senior Manager. They are currently a Ph.D. candidate in Health Policy and Economics at Stanford University, focusing on regulation and pricing in the pharmaceutical and biotechnology industries. Catherine completed their Bachelor of Arts in Economics and Finance, cum laude, at Princeton University and was a visiting student at the University of Oxford. Their professional experience includes roles as a strategy consultant and research assistant, contributing to various organizations in the healthcare sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices